Apixaban Anticoagulation in Children and Young Adults Supported With the HeartMate 3 Ventricular Assist Device

Apixaban

(2022) Katherine R. Whitehouse et al.   ASAIO JOURNAL

Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review

(2019) Wonkyung Byon et al.   CLINICAL PHARMACOKINETICS

Comparison of apixaban to rivaroxaban and enoxaparin in acute cancer‐associated venous thromboembolism

(2019) Waldemar E. Wysokinski et al.   AMERICAN JOURNAL OF HEMATOLOGY

Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation

(2017) Marco Proietti et al.   STROKE

Adverse events in children implanted with ventricular assist devices in the United States: Data from the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS)

(2016) David N. Rosenthal et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH

(2015) S. Kaatz et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Oral Apixaban for the Treatment of Acute Venous Thromboembolism

(2013) Giancarlo Agnelli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apixaban for Extended Treatment of Venous Thromboembolism

(2012) Giancarlo Agnelli et al.   NEW ENGLAND JOURNAL OF MEDICINE